Philadelphia, PA The low molecular weight heparin, enoxaparin, given subcutaneously once or twice daily is as effective and safe as dose-adjusted, continuously infused unfractionated heparin in the ...
Tarrytown, NY - Early phase III results from the PROTECT trial looking at an oral heparin formulation for the prevention of deep vein thrombosis (DVT) in total hip replacement surgery patients show ...
Aspirin alone doesn’t seem to be enough to prevent symptomatic venous thromboembolism (VTE) in the months following total hip or knee replacement for osteoarthritis, results of the CRISTAL trial ...
Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results